"A Phase III, Open-label, Randomized Study To Evaluate The Efficacy And Safety of Adjuvant Alectinib Versus Adjuvant Platinum-based Chemotherapy in Patients with Completely Resected Stage Ib (Tumors≥4 Cm) To Stage IIIa Anaplastic Lymphoma Kinase-positive Non-small Cell Lung Cancer "

drug protocol number
BO40336
drug sponsor
Roche
drug study
ALECTINIB
drug trial site
KFSH&RC-R
drug status
Completed
drug phase